Seminars in Cancer Biology

2.2k papers and 150.1k indexed citations i.

About

The 2.2k papers published in Seminars in Cancer Biology in the last decades have received a total of 150.1k indexed citations. Papers published in Seminars in Cancer Biology usually cover Molecular Biology (1.2k papers), Oncology (862 papers) and Cancer Research (569 papers) specifically the topics of Cancer Cells and Metastasis (228 papers), Epigenetics and DNA Methylation (206 papers) and Cancer Genomics and Diagnostics (175 papers). The most active scholars publishing in Seminars in Cancer Biology are Anupam Bishayee, Gautam Sethi, Mohammad Amjad Kamal, Shahab Uddin and Amirhossein Sahebkar.

In The Last Decade

Fields of papers published in Seminars in Cancer Biology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Seminars in Cancer Biology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Seminars in Cancer Biology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Seminars in Cancer Biology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Seminars in Cancer Biology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025